RadBio, biopharmaceutical solutions for complex chronic diseases.

NICOLAS TAMBUCHO; ANA ROMO

San Francisco, California

Conferencia; Biotech Showcase - JP Morgan Healthcare Conferences; 2020

Demy Colton and EBD Group

RadBio is a clinical-stage biopharmaceutical companyfounded in 2018 and headquartered in Sunchales, Argentina. Th company specializes in developing novel biological drugs for complex chronic diseases such as fibrosis and cancer. RadBio is focused on accelerating the clinical development strategy for non-alcoholic steatohepatitis (NASH) with advanced fibrotic process. Its lead drug product candidate Brecept is able to bind and neutralizeTGF-β and has demonstrated antifibrotic activity in CCl4-induced liver fibrosis in rats as well as antitumoral activity in preliminar in vitro and in vivo models of colorectal cancer.